Cui Tang - Search Results

Year	Number of Results
2003	2
2005	1
2006	2
2007	5
2008	1
2009	6
2010	5
2011	1
2012	2
2013	10
2014	8
2015	9
2016	2
2017	4
2018	5
2019	3
2020	7
2021	7
2022	10
2023	7
2024	5

1

Engineering the Intestinal Lymphatic Transport of Oral Nanoparticles to Educate Macrophages for Cancer Combined Immunotherapy.

Xu L, Weng S, Li S, Wang K, Shen Y, Xu Y, Tang C, Yin C. Xu L, et al. Among authors: tang c. ACS Nano. 2023 Jun 27;17(12):11817-11837. doi: 10.1021/acsnano.3c02985. Epub 2023 Jun 15. ACS Nano. 2023. PMID: 37318192

2

CpG-Conjugated Silver Nanoparticles as a Multifunctional Nanomedicine to Promote Macrophage Efferocytosis and Repolarization for Atherosclerosis Therapy.

Tang C, Wang H, Guo L, Zou C, Hu J, Zhang H, Zhou W, Yang G. Tang C, et al. ACS Appl Mater Interfaces. 2023 Nov 1. doi: 10.1021/acsami.3c11227. Online ahead of print. ACS Appl Mater Interfaces. 2023. PMID: 37910772

3

A Picosecond Delay Generator Optimized by Layout and Routing Based on FPGA.

Zhu M, Cui T, Qi X, Gao Q. Zhu M, et al. Among authors: cui t. Sensors (Basel). 2023 Jul 4;23(13):6144. doi: 10.3390/s23136144. Sensors (Basel). 2023. PMID: 37447991 Free PMC article.

4

Comprehensive Pan-Cancer Analysis of MTF2 Effects on Human Tumors.

Tang C, Lv Y, Ding K, Cao Y, Ma Z, Yang L, Zhang Q, Zhou H, Wang Y, Liu Z, Cao X. Tang C, et al. Curr Probl Cancer. 2023 Jun;47(3):100957. doi: 10.1016/j.currproblcancer.2023.100957. Epub 2023 Mar 30. Curr Probl Cancer. 2023. PMID: 37027952 Free article.

5

Dual targeted delivery of statins and nucleic acids by chitosan-based nanoparticles for enhanced antiatherosclerotic efficacy.

Jiang T, Xu L, Zhao M, Kong F, Lu X, Tang C, Yin C. Jiang T, et al. Among authors: tang c. Biomaterials. 2022 Jan;280:121324. doi: 10.1016/j.biomaterials.2021.121324. Epub 2021 Dec 15. Biomaterials. 2022. PMID: 34933253

6

Carcinosarcoma of the ovary: a case report and literature review.

Zheng J, Tang C, Liu P, Hao H. Zheng J, et al. Among authors: tang c. Front Oncol. 2023 Oct 18;13:1278300. doi: 10.3389/fonc.2023.1278300. eCollection 2023. Front Oncol. 2023. PMID: 37920160 Free PMC article.

7

The role of PEG3 in the occurrence and prognosis of colon cancer.

Zhou T, Lin W, Zhu Q, Renaud H, Liu X, Li R, Tang C, Ma C, Rao T, Tan Z, Guo Y. Zhou T, et al. Among authors: tang c. Onco Targets Ther. 2019 Jul 25;12:6001-6012. doi: 10.2147/OTT.S208060. eCollection 2019. Onco Targets Ther. 2019. PMID: 31413595 Free PMC article.

8

Downregulation of TRIM33 Promotes Survival and Epithelial-Mesenchymal Transition in Gastric Cancer.

Wang F, Wang W, Wu X, Tang C, Du F, Lu Z, Zhang Z, Xu H, Cao X, Li PA. Wang F, et al. Among authors: tang c. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221114505. doi: 10.1177/15330338221114505. Technol Cancer Res Treat. 2022. PMID: 35929141 Free PMC article.

9

Co-delivery of doxorubicin and CRISPR/Cas9 or RNAi-expressing plasmid by chitosan-based nanoparticle for cancer therapy.

Li Q, Lv X, Tang C, Yin C. Li Q, et al. Among authors: tang c. Carbohydr Polym. 2022 Jul 1;287:119315. doi: 10.1016/j.carbpol.2022.119315. Epub 2022 Mar 11. Carbohydr Polym. 2022. PMID: 35422284

10

Excessive activation of HOXB13/PIMREG axis promotes hepatocellular carcinoma progression and drug resistance.

Tang C, Qiu S, Mou W, Xu J, Wang P. Tang C, et al. Biochem Biophys Res Commun. 2022 Oct 1;623:81-88. doi: 10.1016/j.bbrc.2022.07.066. Epub 2022 Jul 19. Biochem Biophys Res Commun. 2022. PMID: 35878427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year